Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells

Cancer Science
Yin-Hsun FengJeng-Chang Lee

Abstract

Sprouty2 (Spry2) is known to increase the expression of epidermal growth factor receptors (EGFR) by conjugating with c-Casitas B-lineage lymphoma (C-Cbl) to decrease protein degradation. The effect of Spry2 on the treatment of gefitinib, a tyrosine kinase inhibitor of EGFR, with regards to colon cancer is still unclear. The half maximal inhibitory concentration (IC50) values of gefitinib in six colon cancer cell lines were assessed. HCT116 and C2BBel cells expressed lower levels of Spry2 protein and were less sensitive to gefitinib, whereas HT29 cells that expressed high levels of Spry2 protein were more sensitive to gefitinib. The sensitivity to gefitinib was increased after overexpression of Spry2 in HCT116 cells, whereas it was decreased after Spry2 knockdown in HT29 cells. The levels of both phosphorylated and total EGFR were increased when HCT116 cells ectopically overexpressed Spry2, with concomitant increase in phosphatase and tensin homolog (PTEN) expression. Inhibition of EGFR by cetuximab reduced sensitivity to gefitinib in HCT116 cells overexpressing Spry2. However, knockdown of PTEN or K-ras failed to diminish the effect of Spry2 on gefitinib sensitivity. Of note, Spry2 enhanced the antitumor effect of gefitinib in ...Continue Reading

References

Jul 15, 1999·The International Journal of Biochemistry & Cell Biology·A Wells
Jul 13, 2002·Expert Review of Anticancer Therapy·Malcolm RansonGordon Jayson
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hisashi NagaharaMasaki Mori
Oct 26, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sandra Van SchaeybroeckPatrick Johnston
Dec 24, 2005·The Journal of Biological Chemistry·Francis EdwinTarun B Patel
Apr 13, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James R TonraDaniel J Hicklin
Apr 19, 2006·Cancer Research·Astrid LièvrePierre Laurent-Puig
Sep 7, 2006·Endocrine-related Cancer·S FritzscheW A Schulz
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mayumi Ono, Michihiko Kuwano
Feb 27, 2007·Current Biology : CB·Hong Joo KimDafna Bar-Sagi
Oct 18, 2007·British Journal of Cancer·M FrattiniL Mazzucchelli
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Astrid LièvrePierre Laurent-Puig
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chang-Qi ZhuUNKNOWN National Cancer Institute of Canada Clinical Trials Group Study BR.21
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jun 12, 2009·BMC Cancer·Ya-Sian ChangJan-Gowth Chang
Jul 28, 2009·Annual Review of Medicine·Neil H Segal, Leonard B Saltz
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David M JackmanBruce E Johnson
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Yves DouillardEdward S Kim
Mar 3, 2010·Biochemical and Biophysical Research Communications·Andrzej S TarnawskiAmrita Ahluwalia

❮ Previous
Next ❯

Citations

Dec 20, 2013·International Journal of Molecular Sciences·Dan FengXiujuan Qu
Apr 20, 2014·Cancer Metastasis Reviews·Samar Masoumi-MoghaddamDavid Lawson Morris
Jan 30, 2015·International Journal of Cancer. Journal International Du Cancer·Samar Masoumi-MoghaddamDavid L Morris
Mar 8, 2011·Expert Opinion on Therapeutic Targets·Christine HeinzleBrigitte Marian
May 3, 2015·Molecular Cancer Research : MCR·Alice M WalshMatthew J Lazzara
Jul 23, 2013·Journal of Cell Science·Alice M Walsh, Matthew J Lazzara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.